Holen Sie sich die Stockscreener-App
1.69
3.98%
-0.07
Handel nachbörslich:
1.68
-0.01
-0.59%
Schlusskurs vom Vortag:
$1.76
Offen:
$1.79
24-Stunden-Volumen:
560.36K
Relative Volume:
0.57
Marktkapitalisierung:
$121.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-292.19M
KGV:
-0.3722
EPS:
-4.54
Netto-Cashflow:
$-208.41M
1W Leistung:
-15.08%
1M Leistung:
+25.19%
6M Leistung:
-16.34%
1J Leistung:
-48.00%
1-Tages-Spanne:
$1.68
$1.79
1-Wochen-Bereich:
$1.68
$2.02
52-Wochen-Spanne:
$1.01
$5.44
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
Firmenname
Zentalis Pharmaceuticals Inc
Sektor
Branche
Telefon
(858) 263-4333
Adresse
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Vergleichen Sie ZNTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZNTL
Zentalis Pharmaceuticals Inc
|
1.69 | 126.96M | 0 | -292.19M | -208.41M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-12 | Hochstufung | Wedbush | Underperform → Neutral |
| 2024-06-20 | Herabstufung | UBS | Buy → Neutral |
| 2024-06-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-18 | Herabstufung | Wedbush | Neutral → Underperform |
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-11-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2022-07-12 | Eingeleitet | Cowen | Outperform |
| 2022-04-06 | Eingeleitet | Wells Fargo | Overweight |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-09-30 | Eingeleitet | Stifel | Buy |
| 2021-09-29 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-21 | Eingeleitet | UBS | Buy |
| 2021-01-20 | Eingeleitet | Wedbush | Outperform |
| 2020-09-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Guggenheim | Buy |
| 2020-04-28 | Eingeleitet | Jefferies | Buy |
| 2020-04-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-04-28 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Zentalis Pharmaceuticals Inc Aktie (ZNTL) Neueste Nachrichten
Zentalis Pharmaceuticals Inc. stock momentum explainedEarnings Growth Summary & Verified Short-Term Plans - Newser
Heatmap analysis for Zentalis Pharmaceuticals Inc. and competitorsJuly 2025 Fed Impact & Accurate Buy Signal Notifications - Newser
Technical signs of recovery in Zentalis Pharmaceuticals Inc.2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser
Using R and stats models for Zentalis Pharmaceuticals Inc. forecastingWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
Should you hold or exit Zentalis Pharmaceuticals Inc. nowQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
Is Zentalis Pharmaceuticals Inc. reversing from oversold territoryWeekly Market Report & Risk Controlled Daily Trade Plans - Newser
Advanced analytics toolkit walkthrough for Zentalis Pharmaceuticals Inc.July 2025 Snapshot & Entry and Exit Point Strategies - Newser
Will Zentalis Pharmaceuticals Inc. outperform the market2025 Trading Volume Trends & Daily Growth Stock Investment Tips - Newser
Can volume confirm reversal in Zentalis Pharmaceuticals Inc.Market Growth Report & Safe Capital Growth Tips - Newser
Why Zentalis Pharmaceuticals Inc. is moving todayGlobal Markets & Weekly Stock Breakout Alerts - Newser
Tools to monitor Zentalis Pharmaceuticals Inc. recovery probabilityWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Using economic indicators to assess Zentalis Pharmaceuticals Inc. potentialEarnings Risk Report & Safe Swing Trade Setup Alerts - Newser
Using portfolio simulators with Zentalis Pharmaceuticals Inc. includedJuly 2025 Rallies & Low Drawdown Trading Strategies - Newser
Published on: 2025-08-29 13:20:30 - Newser
How to use a screener to detect Zentalis Pharmaceuticals Inc. breakoutsPortfolio Value Summary & Stepwise Trade Execution Plans - Newser
Using flow based indicators on Zentalis Pharmaceuticals Inc.Weekly Trend Summary & High Accuracy Trade Signal Alerts - Newser
Using data tools to time your Zentalis Pharmaceuticals Inc. exitTrade Analysis Report & Community Consensus Trade Signals - Newser
Published on: 2025-08-29 05:51:46 - Newser
Tick level data insight on Zentalis Pharmaceuticals Inc. volatility2025 Analyst Calls & AI Driven Stock Reports - Newser
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
Zentalis Pharmaceuticals to Present at Upcoming Investor Conferences in September 2025 - Quiver Quantitative
What to do if you’re stuck in Zentalis Pharmaceuticals Inc.2025 Support & Resistance & Verified Short-Term Trading Plans - Newser
Finanzdaten der Zentalis Pharmaceuticals Inc-Aktie (ZNTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):